GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
77.40
+2.10 (2.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2023. The number of employees decreased by 100 or -9.09% compared to the previous year.
Employees
1,000
Change (1Y)
-100
Growth (1Y)
-9.09%
Revenue / Employee
$267,228
Profits / Employee
-$83,497
Market Cap
2.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,000 | -100 | -9.09% |
Dec 31, 2022 | 1,100 | -100 | -8.33% |
Dec 31, 2021 | 1,200 | 328 | 37.61% |
Dec 31, 2020 | 872 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CONMED | 4,000 |
Premier | 2,900 |
Tandem Diabetes Care | 2,400 |
NeoGenomics | 2,100 |
LeMaitre Vascular | 630 |
TransMedics Group | 584 |
Iovance Biotherapeutics | 557 |
Geron | 141 |
WGS News
- 5 days ago - GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 16 days ago - GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners - Business Wire
- 4 weeks ago - GeneDx to Participate in Upcoming Investor Conference - Business Wire
- 4 weeks ago - GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover - Business Wire
- 4 weeks ago - GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary - Business Wire
- 6 weeks ago - New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields - Business Wire
- 6 weeks ago - GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting - Business Wire
- 7 weeks ago - Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds - Seeking Alpha